Alnylam Pharmaceuticals | Custo De Mercadoria Vendida

Preço das Ações
328.16
Mudança Diária
-3.08 -0.93%
Mensal
-22.33%
Anual
18.82%
Q1 Previsão
318.09




Custo de Mercadoria Vendida Alterar Data
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
Agios Pharmaceuticals USD 1.68M 22K 2025-09
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
Amgen USD 1.79B 128M 2025-12
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Incyte USD 99M 20.23M 2025-09
Ionis Pharmaceuticals USD 2.34M 1.81M 2025-09
Moderna USD 207M 88M 2025-09
Neurocrine Biosciences USD 264M 252.7M 2025-09
Novartis USD 3.54B 216M 2025-09
PTC Therapeutics USD 23.32M 7.83M 2025-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Sanofi EUR 3.76B 344M 2025-12
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Takeda JPY 401.15B 184.07B 2025-12
Ultragenyx Pharmaceutical USD 27.99M 4.99M 2025-09
Vertex Pharmaceuticals USD 414.8M 7.3M 2025-09
Xencor USD 61.66M 50.95M 2025-06


Alnylam Pharmaceuticals Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.